Search

for
Search:

Glossary Nonmelanoma Skin Cancer

refers to skin cancers excluding melanoma, like basal and squamous cell carcinomas

Nonmelanoma Skin Cancer (NMSC) refers to a group of skin cancers that are not melanoma, the most common types being basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). These cancers typically develop in the outer layer of the skin (epidermis) and are usually caused by prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. While NMSC is generally less aggressive than melanoma and has a higher survival rate, early detection and treatment are crucial to prevent potential disfigurement and complications.

Related Terms

Research

5 / 842 results

research Nonmelanoma skin cancer treated with electronic brachytherapy: Results at 1 year

78 citations , January 2013 in “Brachytherapy”

This study found that high-dose-rate electronic brachytherapy was effective for treating nonmelanoma skin cancer, with no recurrences and good to excellent cosmetic results at 1 year or more.

research Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer

12 citations , January 2011 in “Dermatologic Surgery”

This entry contains only a placeholder abstract with no research findings described or summarized.

Human Regulatory T Cells: Role in Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers

research Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers

1 citations , January 2023 in “International Journal of Molecular Sciences”

This review explores the role of Tregs in autoimmune skin diseases, transplantation, and skin cancer, and discusses Tregs-based therapies' potential for treating autoimmunity without reporting new experimental results.

research Effect of Liquid Blood Concentrates on Cell Proliferation and Cell Cycle- and Apoptosis-Related Gene Expressions in Nonmelanoma Skin Cancer Cells: A Comparative In Vitro Study

December 2024 in “International Journal of Molecular Sciences”

This study observed that treating basal and squamous cell carcinoma cells with platelet-rich fibrin significantly reduced cell viability and increased apoptosis-associated gene expression, suggesting potential use as adjunctive therapy for localized nonmelanoma skin cancers.